Neurological Disorder Diagnostics Market, By Technology (Imaging and In Vitro Diagnostics), By Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, and Paraproteinemic Neuropathies), End-User (Hospitals, Specialty Clinics, Diagnostic Centres, and Ambulatory Care Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Neurological disorder is a type of disease that affects brain and central nervous system which results into dysfunction. There are several devices available in the market to diagnose neurological disorders such as computed tomography, magnetic resonance imaging, nuclear medicine imaging, positron emission tomography, single-photon emission computed tomography, biomarker, and biopsy. The global Neurological Disorder Diagnostics market accounted for US$ 12.16 billion in 2020 and is estimated to be US$ 25.01 billion by 2030 and is anticipated to register a CAGR of 7.5%.

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

Increasing technology of neurological disorders

Increasing technological advancement in neurological disorder diagnostics devices is major factor drive growth of the neurological disorder diagnostics devices market. In addition, rising number of cases of chronic diseases across the globe is propelling growth of the global neurological disorder diagnostic devices market. Furthermore, increasing strategic collaboration and acquisition activities among manufacturers operating in the global market in order to enhance product portfolio and global presence are among the major factors expected to further fuel growth of the target market over the forecast period.

However, high cost associated with diagnostics devices factor may hamper growth of the target market.

Neurological disorder diagnostics devices market has been segmented on the basis of technology, disease indication, end-user, and region.

On the basis technology, the target market is classified into imaging and in vitro diagnostics. Imaging technology includes computed tomography, magnetic resonance imaging, nuclear medicine imaging, positron emission tomography, single-photon emission computed tomography, others. Other sub-segment includes near infrared spectroscopic imaging, electroencephalography, magnetoencephalography. In vitro diagnostics technology segment includes biomarker and biopsy. Based on disease segmentation, the target is bifurcated into genetic neurological disorders, immunological neurological disorders, paraneoplastic syndrome, and paraproteinemic neuropathies. Genetic neurological disorders include sub-segments such as alzheimer's disease, parkinson's disease, and others. Others includes amyotrophic lateral sclerosis and huntington's disease. On the basis of end user, the global market is categorized into hospitals, specialty clinics, diagnostic centers, and ambulatory care centres.

Regional Insights:

The global Neurological Disorder Diagnostics market accounted for US$ 12.16 billion in 2020 and is estimated to be US$ 25.01 billion by 2030 and is anticipated to register a CAGR of 7.5%. On the basis of region, the global neurological disorder diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the target market and is expected to continue its dominance over the forecast period, owing to rising adoption of new diagnostics devices and well developed healthcare sector in this region. The Europe is projected to register second largest share in terms of revenue over the forecast period due to rising innovation and technological advancement in medical devices in this region. Asia Pacific is projected to witness significant growth over the forecast period. This is attributed to increasing adoption of medical devices by end users in this region

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Neurological Disorder Diagnostics market report based on technology, Disease Indication, End-User, and region.

Neurological Disorder Diagnostics Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

Key players in the neurological disorder diagnostics devices market include Siemens Healthineers Inc., Koninklijke Philips N.V., Esaote S.p.A, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems Co., Ltd., and Canon Medical Systems Corporation, and Abbott Laboratories.

• Siemens Healthineers Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Koninklijke Philips N.V.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Esaote S.p.A
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• NeuroLogica Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Masimo Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• York Instruments Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Neusoft Medical Systems Co. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Canon Medical Systems Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Abbott Laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies